Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:In vitro effects of different biomaterials on canine dental pulp stem cells
Authors:ID Marx, Robert (Author)
ID Nemec, Ana (Author)
ID Kocjan, Andraž, Institut "Jožef Stefan" (Author)
ID Voga, Metka (Author)
Files:URL URL - Source URL, visit https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2026.1758525/full
 
.pdf PDF - Presentation file, download (2,83 MB)
MD5: C4322F5481BEDFA81B02CD12CDC2B2C5
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo IJS - Jožef Stefan Institute
Abstract:Objective: Regenerative endodontic treatments are being developed in veterinary dentistry. The aim of this study was to evaluate the biocompatibility and odontogenic potential of three biomaterials, ProRoot® MTA (MTA), RS + ™ (RS+), and CellFoam™ (CF), on canine dental pulp stem cells (cDPSCs) under conditions simulating early and clinically relevant exposures.Methods: cDPSCs were isolated from three healthy dog teeth extracted for clinical reasons and characterized by flow cytometry (CD44+/CD90+/CD29+/CD34−) and multilineage differentiation. Cells were cultured with material suspensions (acute cytotoxic effect) or conditioned medium (physiologically relevant effect). Metabolic activity and cell viability were assessed by MTT and live/dead assays. Osteogenic/odontogenic differentiation was evaluated by Alizarin Red S staining and RT–qPCR for RUNX2, ALPL, and MMP13 expression.Results: In suspension cultures, compared with MTA and RS+, CF maintained significantly higher metabolic activity and cell viability across several dilutions, indicating lower acute cytotoxicity. Under conditioned exposure, no significant differences among materials were observed, reflecting the dilution and buffering effects that mitigate early reactivity. All the materials supported Alizarin Red S-positive mineral deposition, with a significant difference at D3, when ARS staining of cDPSCs was greater in cells conditioned with MTA than in those conditioned with CF. Gene expression analysis revealed lower RUNX2 and ALPL expression in MTA-conditioned cells, suggesting, together with ARS staining, progression toward a more advanced osteogenic or odontogenic differentiation stage. MMP13 expression remained comparable across materials.Conclusion: MTA, RS+, and CF demonstrated overall biocompatibility with cDPSCs and supported odontogenic differentiation under clinically relevant conditions. CF exhibited the lowest acute cytotoxicity, indicating its potential as a carrier for DPSC-based regenerative endodontic applications. These findings support the translational importance of in vitro cDPSC models for evaluating biomaterial performance in veterinary regenerative endodontics.
Publication status:Published
Publication version:Version of Record
Submitted for review:01.12.2025
Article acceptance date:19.01.2026
Publication date:05.02.2026
Publisher:Frontiers
Year of publishing:2026
Number of pages:str. 1-13
Numbering:Vol. 13, [article no.] 1758525
Source:Švica
PID:20.500.12556/DiRROS-27672 New window
UDC:620.1/.2
ISSN on article:2297-1769
DOI:10.3389/fvets.2026.1758525 New window
COBISS.SI-ID:268070659 New window
Copyright:© 2026 Marx, Nemec, Kocjan and Voga.
Note:Nasl. z nasl. zaslona; Soavtorji: Ana Nemec, Andraž Kocjan, Metka Voga; Opis vira z dne 11. 2. 2026;
Publication date in DiRROS:18.02.2026
Views:41
Downloads:18
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in veterinary science
Shortened title:Front. vet. sci.
Publisher:Frontiers Media S.A.
ISSN:2297-1769
COBISS.SI-ID:3969402 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0455-2024
Name:Veterinarska regenerativna medicina

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0087-2019
Name:Keramični in komplementarni materiali za napredne inženirske in biomedicinske aplikacije

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:05.02.2026
Applies to:VoR

Back